Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study

NCT01075100 is registered in ClinicalTrials.gov with US Oncology Research as lead sponsor.

NCT NCT01075100
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01075100 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Ixabepilone Plus Carboplatin in Patients With Metastatic Breast Cancer: The ECLIPSE Study
Lead sponsor
US Oncology Research
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2010
Completion date
June 30, 2013
Enrollment
103 (actual)
Sites
59

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic breast cancer